编辑委员会对放射化学与放射性药物发展的重点选择。

Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

作者信息

Alves Francisco, Antunes Inês F, Cazzola Emiliano, Cleeren Frederik, Cornelissen Bart, Denkova Antonia, Engle Jonathan, Faivre-Chauvet Alain, Gillings Nic, Hendrikx Jeroen J M A, Jalilian Amir R, van der Meulen Nicholas P, Mikolajczak Renata, Neels Oliver C, Pillai Maroor R A, Reilly Raymond, Rubow Sietske, Seimbille Yann, Spreckelmeyer Sarah, Szymanski Wiktor, Taddei Carlotta

机构信息

University of Coimbra, Coimbra, Portugal.

UMCG, Groningen, The Netherlands.

出版信息

EJNMMI Radiopharm Chem. 2021 Sep 8;6(1):31. doi: 10.1186/s41181-021-00146-9.

DOI:10.1186/s41181-021-00146-9

PMID:34495412

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8426445/

Abstract

BACKGROUND

The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development.

RESULTS

This commentary of highlights has resulted in 21 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Also the first contribution in relation to MRI-agents is included.

CONCLUSIONS

Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

摘要